Cardiovascular Device Update articles from November 2006

Cardiovascular Device Update archives from November 2006

Advances in cardiovascular imaging, vulnerable plaque detection in Europe.
November 1, 2006... Advances in cardiovascular imaging, vulnerable plaque detection in Europe By MIKE SIMONSEN, PhD CDU Contributing Editor BARCELONA -- Cardiovascular diseases are the major cause of death throughout Europe, accounting formore than 4...

Alternative materials offer surprising new options vs. stenting.
November 1, 2006... Alternative materials offer surprising new options vs. stenting By MARK McCARTY CDU Washington Editor As the current debate over the safety and efficacy of drug-eluting stents demonstrates, veins and arteries aren't simply...

Hypertension IDE granted for Rheos.
November 1, 2006... Hypertension IDE granted for Rheos By HOLLAND JOHNSON CDU Associate Managing Editor CVRx (Minneapolis) received FDA approval for conditional investigational device exemption (IDE) for its Rheos baroreflex hypertension therapy...

Adverse cardio event reporting guidelines rolled out by HRS.(Heart Rhythm Society)
November 1, 2006... Adverse cardio event reporting guidelines rolled out by HRS By MARK McCARTY CDU Washington Editor The Heart Rhythm Society (HRS; Washington) last month issued its long-awaited list of recommendations for reporting malfunctions and...

Acorn to test its fate before dispute panel.
November 1, 2006... Acorn to test its fate before dispute panel By HOLLAND JOHNSON CDU Associate Managing Editor For only the second time since its creation, the FDA's Medical Devices Dispute Resolution Panel (MDDRP) will determine the fate of a...

International report.
November 1, 2006... International report New transcatheter valve CE marking won by Medtronic Signaling what it said is a "new frontier in the use of transcatheter valve technology," Medtronic (Minneapolis) has received the CE mark for its Melody...

Acquisitions.
November 1, 2006... Acquisitions * In a move that may augur a more concentrated focus in the medical device market, pharmaceutical powerhouse Merck (Whitehouse Station, New Jersey) last month agreed to acquire a roughly 11% stake in FoxHollow Technologies...

Business Developments.
November 1, 2006... Business Developments Abbott drops ZoMaxx, launches Xience V DES into Europe In a move based primarily on clinical data, Abbott Laboratories (Abbott Park, Illinois) last month reported that it was scrapping its ZoMaxx drug-eluting...

Agreements.
November 1, 2006... Agreements * Abbott (Abbott Park, Illinois) reported signing an agreement with Blood Systems Laboratories (Scottsdale, Arizona) to supply its Prism System automated blood screening instruments and assays at Blood Systems' U.S. blood donor...

Market Updates.
November 1, 2006... Market Updates Editorial could add to questions about overuse of DES In the wake of recent concerns about the long-term safety of drug-eluting stents (DES), including presentations last month at the World Congress of Cardiology (WCC;...

Personnel File.(AtCor Medical Pty Ltd)(ATS Medical Inc.)(OmniSonics Medical Technologies Inc.)
November 1, 2006... Personnel File * AtCor Medical (West Ryde, Australia) reported that Duncan Ross will become CEO of the company at the annual general meeting on Nov. 9. Ross will succeed Ross Harricks, the co-founder of AtCor, who will remain an executive...

Product Pipeline.
November 1, 2006... Product Pipeline Earliest cases show success with Tryton's Side-Branch Stent For years, surgeons have attempted to treat Y-shaped bifurcation coronary artery lesions using stents that are designed for straight vessels, the equivalent...